It’s not all about control: challenging mainstream framing of eating disorders - Journal of Eating Disorders

  • 📰 BioMedCentral
  • ⏱ Reading Time:
  • 59 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 27%
  • Publisher: 71%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

In a Comment article published in the Journal of Eating Disorders, the authors argue that although control can play a role in eating disorder experiences, overemphasis upon this factor can result in other important factors being overlooked.

]. This tendency is reflective of the portrayal and understanding of EDs in our society at the moment.

My first contact with service users typically includes a period of assessment and psychological formulation , and within these early conversations the idea of control is frequently raised. Not by me or other members of the multi-disciplinary team- but by the individual suffering. Therefore, for many individuals with an eating disorder the concept of control is meaningful, and validating their lived experience should be our first priority.

Given these experiences, it is unsurprising that people are motivated to change their eating habits if, for them, it helps instill a sense of control. However, it is crucial we don’t oversimplify the construct of control or view it as an undesirable personality trait.

Despite some differences in our approaches, we both reflected upon how we inevitably seek to see the bigger picture and try not to fall into the trap of reductionism. That said, we appreciate that the field could do more to critique the specific language that is universally used in relation to control, hence our involvement with this position piece. Reframing EDs through the language we use could potentially be very powerful.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 22. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

The sense of stopping migraine prophylaxis - The Journal of Headache and PainIntroduction Migraine prophylactic therapy has changed over recent years with the development and approval of monoclonal antibodies (mAbs) targeting the calcitonin gene-related peptide (CGRP) pathway. As new therapies emerged, leading headache societies have been providing guidelines on the initiation and escalation of such therapies. However, there is a lack of robust evidence looking at the duration of successful prophylaxis and the effects of therapy discontinuation. In this narrative review we explore both the biological and clinical rationale for prophylactic therapy discontinuation to provide a basis for clinical decision-making. Methods Three different literature search strategies were conducted for this narrative review. These include i) stopping rules in comorbidities of migraine in which overlapping preventives are prescribed, notably depression and epilepsy; ii) stopping rules of oral treatment and botox; iii) stopping rules of antibodies targeting the CGRP (receptor). Keywords were utilized in the following databases: Embase, Medline ALL, Web of Science Core collection, Cochran Central Register of Controlled Trials, and Google Scholar. Discussion Reasons to guide decision-making in stopping prophylactic migraine therapies include adverse events, efficacy failure, drug holiday following long-term administration, and patient-specific reasons. Certain guidelines contain both positive and negative stopping rules. Following withdrawal of migraine prophylaxis, migraine burden may return to pre-treatment level, remain unchanged, or lie somewhere in-between. The current suggestion to discontinue CGRP(-receptor) targeted mAbs after 6 to 12 months is based on expert opinion, as opposed to robust scientific evidence. Current guidelines advise the clinician to assess the success of CGRP(-receptor) targeted mAbs after three months. Based on excellent tolerability data and the absence of scientific data, we propose if no other reasons apply, to stop the use of mAbs wh
Source: BioMedCentral - 🏆 22. / 71 Read more »

I was a zombie after flesh eating disease ate my face - don’t make my mistakeA WOMAN is urging people to visit their dentist after a flesh eating disease “skinned” her alive. Meg Urquhart, 49, cancelled a medical appointment last spring when gum pain from an abs…
Source: TheSun - 🏆 64. / 61 Read more »

Dan Walker's health update after bike accident left him eating through strawThe former BBC Breakfast host has offered a fresh update as he recovers from being knocked off his bike It wasn't an accident, it was a collision or crash - a driver drove their car into Dan's bike, knocking him off. Why not say current channel 5 presenter?
Source: MENnewsdesk - 🏆 23. / 69 Read more »